APA (7th ed.) Citation

Coghill, D., & Banaschewski, T. (2017). Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD: A phase IV, 2-year, open-label study in Europe. CNS drugs, 31(7), . https://doi.org/10.1007/s40263-017-0443-y

Chicago Style (17th ed.) Citation

Coghill, David, and Tobias Banaschewski. "Long-term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-year, Open-label Study in Europe." CNS Drugs 31, no. 7 (2017). https://doi.org/10.1007/s40263-017-0443-y.

MLA (9th ed.) Citation

Coghill, David, and Tobias Banaschewski. "Long-term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-year, Open-label Study in Europe." CNS Drugs, vol. 31, no. 7, 2017, https://doi.org/10.1007/s40263-017-0443-y.